WO2024157170 - PROCESS FOR THE PREPARATION OF TIVOZANIB OR A SALT THEREOF

National phase entry is expected:
Publication Number WO/2024/157170
Publication Date 02.08.2024
International Application No. PCT/IB2024/050628
International Filing Date 23.01.2024
Title **
[English] PROCESS FOR THE PREPARATION OF TIVOZANIB OR A SALT THEREOF
[French] PROCÉDÉ DE PRÉPARATION DE TIVOZANIB OU D'UN SEL DE CELUI-CI
Applicants **
GLENMARK LIFE SCIENCES LIMITED
Inventors
PALLE, Venkata Raghavendra Acharyulu
PATEL, Pratik
SHANMUGHASAMY, Raj Mahendra
YADAV, Premkumar Ramraj
Priority Data
202321005054   25.01.2023   IN
Application details
Total Number of Claims/PCT *
Number of Independent Claims *
Number of Priorities *
Number of Multi-Dependent Claims *
Number of Drawings *
Pages for Publication *
Number of Pages with Drawings *
Pages of Specification *
*
Number of Office Actions *
*
International Searching Authority
*
Recordal of a Change of the Applicant's Name/Address
*
Type of Assignment
*
Applicant's Legal Status
*
*
*
*
*
*
Entry into National Phase under
*
Patent Delivery
*
Translation

* The data is based on automatic recognition. Please verify and amend if necessary.

** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.

Quotation for National Phase entry

Country StagesTotal
China Filing, Examination, Granting2052
EPO Filing, Examination, Granting11845
Japan Filing, Examination, Granting2149
South Korea Filing, Examination, Granting1973
USA Filing, Examination, Granting4740
MasterCard Visa
Total: 22,759

The term for entry into the National Phase has expired. This quotation is for informational purposes only

Abstract[English] The present invention relates to a process for the preparation of tivozanib or a pharmaceutically acceptable salt or a hydrate thereof. The present invention particularly relates to a process for the preparation of tivozanib hydrochloride or a hydrate thereof. The present invention also relates to a process for the purification of tivozanib or a pharmaceutically acceptable salt thereof.[French] La présente invention concerne un procédé de préparation de tivozanib ou d'un sel pharmaceutiquement acceptable ou d'un hydrate de celui-ci. La présente invention concerne en particulier un procédé de préparation de chlorhydrate de tivozanib ou d'un hydrate de celui-ci. La présente invention concerne également un procédé de purification de tivozanib ou d'un sel pharmaceutiquement acceptable de celui-ci.

Rejoining the server...